Prime Minister’s Youth Programme Chairman Rana Mashhood Ahmed Khan said on Monday that a vigorous awareness campaign was ...

Thalassemia continues to be a significant health challenge in India, but with advancements in healthcare, early diagnosis, ...

Conditions such as alpha thalassemia major, where the fetus cannot produce adequate red blood cells ... The condition can ...

Iron overload remains a significant challenge in the management of β-thalassemia. Early diagnosis and regular monitoring are crucial for preventing organ damage. While chelation therapy is the ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center ...

Nagpur: In a significant development, renowned paediatrician Dr Vinky Rughwani has been nominated to the National Medical ...

CRISPR Therapeutics' first therapy is called Casgevy. It treats sickle cell disease (SCD) and beta thalassemia, both rare ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

Crispr Therapeutics 40% share in Casgevy could result in revenue annual between $1.2 billion and $2.8 billion towards the end ...

Tebapivat, a novel pyruvate kinase activator, is being investigated for the treatment of anemia in patients with lower-risk ...

BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...